Lionbridge Technologies, Inc., the translation and digital communications company, announced updates to its Clinical Labeling translation solution, an end-to-end offering that helps global life sciences organizations translate labeling content for clinical studies while remaining compliant with global regulatory requirements.
The features of the Clinical Labeling solution include an updated, fully customizable workflow for label text creation, translation and validation across more than 100 markets and languages. In addition, Lionbridge Life Sciences has integrated its labeling translation solution with suppliers of clinical labeling design, production, and management services, allowing integration of translation processes within clients' existing labeling management platforms.
"As a global leader in clinical supply chain solutions, we needed a partner that could deliver accurate clinical labels while integrating regulatory compliance, packaging capabilities and country validation," said Jamie Pieron, Manager of Client Services Operations, Clintrak Clinical Labeling Services. "By leveraging Lionbridge's expansive global regulatory network and expertise, we can continue to provide our clients with a clinical labeling model that improves efficiency and reduces overall risk."
Lionbridge's technology platform, combined with Lionbridge's network of qualified translators and regulatory experts enables pharmaceutical and biotechnology organizations to reduce the overall label cycle times and simplify global label creation. Key benefits of the updated Lionbridge Clinical Labeling solution include:
To learn more, visit http://lifesciences.lionbridge.com/what-we-do/services-function/regulatory/.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.